Benovic J L, Stone W C, Caron M G, Lefkowitz R J
Department of Medicine, Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710.
J Biol Chem. 1989 Apr 25;264(12):6707-10.
The beta-adrenergic receptor kinase, which specifically phosphorylates the agonist-occupied beta-adrenergic receptor, is strongly inhibited by polyanions. Heparin and dextran sulfate inhibit the enzyme with an IC50 of approximately 0.15 microM. De-N-sulfated heparin is approximately 8-fold less potent. Other acid mucopolysaccharides such as heparan sulfate and chondroitin sulfates B and C are also less effective. Polyaspartic and polyglutamic acid also inhibit with IC50 values of 1.3-2 microM. Inositol hexasulfate, with an IC50 of 13 microM is approximately 270-fold more potent than inositol hexaphosphate implicating the sulfate group as a major determinant of the inhibition. The inhibition by heparin is competitive with substrate and of mixed type with respect to ATP. Polycations also inhibit receptor phosphorylation by beta-adrenergic receptor kinase. Polylysine is more effective with an IC50 of 69 microM, while spermine (990 microM) and spermidine (2570 microM) are less potent. Polylysine, spermine, and spermidine are also able to block effectively the inhibition by heparin. The identification of compounds which specifically inhibit beta-adrenergic receptor kinase should prove useful in further defining the biological role of this enzyme.
β-肾上腺素能受体激酶可特异性地使被激动剂占据的β-肾上腺素能受体磷酸化,它受到多聚阴离子的强烈抑制。肝素和硫酸葡聚糖对该酶的抑制IC50约为0.15微摩尔。去N-硫酸化的肝素效力约低8倍。其他酸性粘多糖如硫酸乙酰肝素以及硫酸软骨素B和C的效力也较低。聚天冬氨酸和聚谷氨酸也有抑制作用,IC50值为1.3 - 2微摩尔。肌醇六硫酸酯的IC50为13微摩尔,其效力比肌醇六磷酸约高270倍,这表明硫酸基团是抑制作用的主要决定因素。肝素的抑制作用与底物竞争,对ATP而言属于混合型抑制。多阳离子也抑制β-肾上腺素能受体激酶的受体磷酸化作用。聚赖氨酸更有效,IC50为69微摩尔,而精胺(990微摩尔)和亚精胺(2570微摩尔)的效力较低。聚赖氨酸、精胺和亚精胺也能有效阻断肝素的抑制作用。鉴定特异性抑制β-肾上腺素能受体激酶的化合物对于进一步明确该酶的生物学作用应是有用的。